Literature DB >> 24725411

KRas localizes to the plasma membrane by spatial cycles of solubilization, trapping and vesicular transport.

Malte Schmick1, Nachiket Vartak1, Björn Papke1, Marija Kovacevic1, Dina C Truxius1, Lisaweta Rossmannek1, Philippe I H Bastiaens2.   

Abstract

KRas is a major proto-oncogene product whose signaling activity depends on its level of enrichment on the plasma membrane (PM). This PM localization relies on posttranslational prenylation for membrane affinity, while PM specificity has been attributed to electrostatic interactions between negatively charged phospholipids in the PM and basic amino-acids in the C terminus of KRas. By measuring kinetic parameters of KRas dynamics in living cells with a cellular-automata-based data-fitting approach in realistic cell-geometries, we show that charge-based specificity is not sufficient to generate PM enrichment in light of the total surface area of endomembranes. Instead, mislocalized KRas is continuously sequestered from endomembranes by cytosolic PDEδ to be unloaded in an Arl2-dependent manner to perinuclear membranes. Electrostatic interactions then trap KRas at the recycling endosome (RE), from where vesicular transport restores enrichment on the PM. This energy driven reaction-diffusion cycle explains how small molecule targeting of PDEδ affects the spatial organization of KRas.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24725411     DOI: 10.1016/j.cell.2014.02.051

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  104 in total

1.  The N- and C-terminal ends of RPGR can bind to PDE6δ.

Authors:  Eyad Kalawy Fansa; Nicola J O'Reilly; Shehab Ismail; Alfred Wittinghofer
Journal:  EMBO Rep       Date:  2015-11-09       Impact factor: 8.807

Review 2.  Targeting RAS Membrane Association: Back to the Future for Anti-RAS Drug Discovery?

Authors:  Adrienne D Cox; Channing J Der; Mark R Philips
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

Review 3.  Posttranslational Modifications of RAS Proteins.

Authors:  Ian Ahearn; Mo Zhou; Mark R Philips
Journal:  Cold Spring Harb Perspect Med       Date:  2018-11-01       Impact factor: 6.915

4.  Blue light-triggered photochemistry and cytotoxicity of retinal.

Authors:  Kasun Ratnayake; John L Payton; Mitchell E Meger; Nipunika H Godage; Emanuela Gionfriddo; Ajith Karunarathne
Journal:  Cell Signal       Date:  2020-01-23       Impact factor: 4.315

Review 5.  Biology, pathology, and therapeutic targeting of RAS.

Authors:  J Matthew Rhett; Imran Khan; John P O'Bryan
Journal:  Adv Cancer Res       Date:  2020-07-09       Impact factor: 6.242

6.  FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage.

Authors:  Hanna Parkkola; Farid Ahmad Siddiqui; Christina Oetken-Lindholm; Daniel Abankwa
Journal:  Methods Mol Biol       Date:  2021

7.  Understanding Ras Spatial Cycles Through Reaction-Diffusion Simulations.

Authors:  Malte Schmick; Philippe I H Bastiaens
Journal:  Methods Mol Biol       Date:  2021

8.  Spatiotemporal imaging of small GTPases activity in live cells.

Authors:  Stephanie Voss; Dennis M Krüger; Oliver Koch; Yao-Wen Wu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-29       Impact factor: 11.205

9.  AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.

Authors:  Kwang-Jin Cho; Darren E Casteel; Priyanka Prakash; Lingxiao Tan; Dharini van der Hoeven; Angela A Salim; Choel Kim; Robert J Capon; Ernest Lacey; Shane R Cunha; Alemayehu A Gorfe; John F Hancock
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

Review 10.  The Mystery of Rap1 Suppression of Oncogenic Ras.

Authors:  Ruth Nussinov; Hyunbum Jang; Mingzhen Zhang; Chung-Jung Tsai; Anna A Sablina
Journal:  Trends Cancer       Date:  2020-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.